Search research articles
Contact Us
Filters
Showing results (31-40 of 47) with videos related to
Page
of 5
Sort By:
Cancer Research
|
March 14, 2001
The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer
S A Ahmad, W Liu, Y D Jung, et al.
British Journal of Cancer
|
October 29, 2002
Angiopoietin-1 inhibits tumour growth and ascites formation in a murine model of peritoneal carcinomatosis
O Stoeltzing, S A Ahmad, W Liu, et al.
The European Respiratory Journal
|
February 14, 2009
Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment
M Kreuter, M Kropff, A Fischaleck, et al.
British Journal of Cancer
|
February 5, 2004
ZD6126 inhibits orthotopic growth and peritoneal carcinomatosis in a mouse model of human gastric cancer
M F McCarty, A Takeda, O Stoeltzing, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
May 10, 2001
Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival
N Reinmuth, W Liu, Y D Jung, et al.
British Journal of Cancer
|
August 17, 2001
Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors
R M Shaheen, S A Ahmad, W Liu, et al.
International Journal of Oncology
|
February 15, 2001
Effects of an antibody to vascular endothelial growth factor receptor-2 on survival, tumor vascularity, and apoptosis in a murine model of colon carcinomatosis
R M Shaheen, W W Tseng, R Vellagas, et al.
Cancer Research
|
March 14, 2001
Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms
R M Shaheen, W W Tseng, D W Davis, et al.
Diagnostic Pathology
|
July 29, 2015
Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?
I Watermann, B Schmitt, F Stellmacher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 24, 2020
ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer
D Planchard, N Reinmuth, S Orlov, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 47) with videos related to
Sort By:
Page
of 5
Cancer Research
|
March 14, 2001
The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer
S A Ahmad, W Liu, Y D Jung, et al.
British Journal of Cancer
|
October 29, 2002
Angiopoietin-1 inhibits tumour growth and ascites formation in a murine model of peritoneal carcinomatosis
O Stoeltzing, S A Ahmad, W Liu, et al.
The European Respiratory Journal
|
February 14, 2009
Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment
M Kreuter, M Kropff, A Fischaleck, et al.
British Journal of Cancer
|
February 5, 2004
ZD6126 inhibits orthotopic growth and peritoneal carcinomatosis in a mouse model of human gastric cancer
M F McCarty, A Takeda, O Stoeltzing, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
May 10, 2001
Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival
N Reinmuth, W Liu, Y D Jung, et al.
British Journal of Cancer
|
August 17, 2001
Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors
R M Shaheen, S A Ahmad, W Liu, et al.
International Journal of Oncology
|
February 15, 2001
Effects of an antibody to vascular endothelial growth factor receptor-2 on survival, tumor vascularity, and apoptosis in a murine model of colon carcinomatosis
R M Shaheen, W W Tseng, R Vellagas, et al.
Cancer Research
|
March 14, 2001
Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms
R M Shaheen, W W Tseng, D W Davis, et al.
Diagnostic Pathology
|
July 29, 2015
Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?
I Watermann, B Schmitt, F Stellmacher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 24, 2020
ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer
D Planchard, N Reinmuth, S Orlov, et al.
Page
of 5